ATG4C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.471600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.220010E-01
Normal-vs-Stage2
2.499800E-01
Normal-vs-Stage3
1.085380E-01
Normal-vs-Stage4
3.590400E-01
Stage1-vs-Stage2
9.035400E-01
Stage1-vs-Stage3
5.839200E-01
Stage1-vs-Stage4
4.078800E-01
Stage2-vs-Stage3
4.927400E-01
Stage2-vs-Stage4
1.848390E-01
Stage3-vs-Stage4
2.054800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.469000E-01
Normal-vs-AfricanAmerican
1.613820E-01
Normal-vs-Asian
8.020600E-03
Caucasian-vs-AfricanAmerican
4.998000E-01
Caucasian-vs-Asian
1.320380E-01
AfricanAmerican-vs-Asian
1.406380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.997630E-03
Normal-vs-Female
2.774600E-01
Male-vs-Female
6.642200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.967190E-01
Normal-vs-Age(41-60Yrs)
2.831600E-01
Normal-vs-Age(61-80Yrs)
3.219700E-03
Normal-vs-Age(81-100Yrs)
2.377400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.673400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.211400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.194200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.290620E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.605600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.796200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.123000E-01
Normal-vs-Daily Drinker
1.816370E-01
Normal-vs-Weekly Drinker
1.819730E-02
Normal-vs-Occasional Drinker
2.066300E-02
Normal-vs-Social Drinker
7.548400E-02
Non Drinker-vs-Daily Drinker
3.029400E-01
Non Drinker-vs-Weekly Drinker
8.961000E-01
Non Drinker-vs-Occasional Drinker
2.015000E-01
Non Drinker-vs-Social Drinker
1.555020E-01
Daily Drinker-vs-Weekly Drinker
5.686400E-01
Daily Drinker-vs-Occasional Drinker
2.775500E-02
Daily Drinker-vs-Social Drinker
6.053600E-02
Weekly Drinker-vs-Occasional Drinker
2.912600E-01
Weekly Drinker-vs-Social Drinker
2.592200E-01
Occasional Drinker-vs-Social Drinker
7.686600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.354400E-01
Normal-vs-Grade 2
9.730400E-01
Normal-vs-Grade 3
9.903800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.925830E-01
Grade 1-vs-Grade 3
4.583800E-01
Grade 1-vs-Grade 4
9.354400E-01
Grade 2-vs-Grade 3
5.293600E-01
Grade 2-vs-Grade 4
9.730400E-01
Grade 3-vs-Grade 4
9.903800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.663200E-03
Normal-vs-NonDiabetic
2.139800E-01
Diabetic-vs-NonDiabetic
2.028800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.808190E-01
Normal-vs-NoPancreatitis
2.338800E-01
Pancreatitis-vs-NoPancreatitis
1.544980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.942700E-03
Normal-vs-N1
2.557600E-01
N0-vs-N1
5.813000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.751200E-01
Normal-vs-TP53-NonMutant
3.667000E-01
TP53-Mutant-vs-TP53-NonMutant
6.591900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
